While there are few silver linings to the cloud created by COVID-19, the pandemic that has killed tens of thousands, hobbled economies worldwide and drove millions to quarantine in their homes, one may be a new appreciation of telemedicine. “If something good could come out of this crisis, it’s that…
News
The National Organization for Rare Disorders (NORD) has opened a financial assistance program for people in rare disease community who are affected by the COVID-19 pandemic in the U.S. Called the NORD COVID-19 Critical Relief Program, the effort will provide up to $1,000 annually to those eligible to…
Heart Surgery in CAD Patients Can Be Performed Safely with Certain Adjustments, Study Indicates
Heart surgery can be performed safely in people with cold agglutinin disease (CAD) by adopting a series of procedure adjustments, according to a case study. The study, “Cardiopulmonary bypass strategy in a patient with cold agglutinin of high thermal amplitude,” was published in the journal…
First, the bad news: If you’re one of the 30 million or so Americans with a rare disease, you probably have lower immunity to the novel coronavirus than most people. Now, the good news: You already know how to face loneliness and adversity — qualities that make you far stronger…
People with cold agglutinin disease (CAD) have genetic alterations previously reported in patients with marginal zone lymphoma (MZL), suggesting the disorders might be related, study reports. The study, “Cold agglutinin–associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18,” was…
The Living Rare, Living Stronger Patient and Family Forum, originally set for May 14–16 in Cleveland, Ohio, has been postponed until July 18–20 because of the coronavirus disease COVID-19 pandemic. The event’s sponsor, the National Organization for Rare Disorders (NORD),…
Even with the coronavirus pandemic ravaging Europe and much of the world, patient advocate Lucia Monaco, PhD, of Italy remains confident that the Paris-based nonprofit she chairs will see the approval of 1,000 new rare disease therapies by 2027. That group, the International Rare Diseases Research Consortium (IRDiRC) —…
Long-term maintenance treatment with sutimlimab is safe, prevents red blood cell destruction, and increases the amount of hemoglobin in people with cold agglutinin disease (CAD), avoiding the need for blood transfusions. Those findings are detailed in the study “Inhibition of complement C1s in patients with cold…
Emotional resilience is a term used to describe how people respond to changes and their ability to adapt to stressful situations. Being resilient doesn’t mean that people don’t experience or feel the stress but it refers to how quickly they can “bounce back” or adapt to crises. Resilience can…
Cold agglutinin disease can lead to serious complications during pregnancy, according to a case study of two women with autoimmune hemolytic anemia (AIHA). The study’s researchers emphasized the importance of a complete molecular diagnosis of AIHA to estimate maternal and fetal risks, and to establish…
Recent Posts
- A blue-goo fiasco reminded me of new CAD treatments on the horizon
- 3 cases illustrate difference among AIHA types, treatments
- At last, some answers for this CAD patient’s stubborn fatigue
- Potential therapy for rare blood disorders acquired by companies
- Issues pile up when I neglect the management of both CAD and my yard
- Enjaymo, warmth protect CAD patient during surgery: Case report
- After 50 years, my husband and I have ‘only just begun’
- Why I said no to yet another CAD blood test
- Enjaymo brings lasting gains for CAD patient misdiagnosed with cancer
- Myeloid leukemia turns up as hidden cause of CAD: Case study